Presence of CD34+cells in the CSF after G-CSF induced mobilisation and mannitol treatment in patients with amyotrophic lateral sclerosis

被引:0
|
作者
Bossolasco, P.
Morelli, C.
Servida, F.
Lunetta, C.
Onida, F.
Argenton, S.
Corbo, M.
Deliliers, G. Lambertenghi
Silani, V.
机构
[1] Univ Milan, Milan, Italy
[2] Hosp Niguarda Ca Granda, Milan, Italy
[3] Lanzo Hosp, Lanzo dIntelvi, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:58 / 58
页数:1
相关论文
共 50 条
  • [31] CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF
    Cesana, C
    Carlo-Stella, C
    Regazzi, E
    Garau, D
    Sammarelli, G
    Caramatti, C
    Tabilio, A
    Mangoni, L
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 1998, 21 (06) : 561 - 568
  • [32] Is there a correlation between peripheral blood CD34+cells and peripheral blood erythrocyte precursors in healthy G-CSF stimulated donors and the effect of G-CSF and apheresis on complete blood count
    Tavat, C
    Arslan, O
    Arat, M
    Ilhan, O
    Ozcan, M
    Topcuoglu, P
    Beksac, M
    Akan, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S236 - S236
  • [33] Mobilisation of PBSC with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with lymphoma.
    McQuaker, IG
    Haynes, AP
    Stainer, C
    Byrne, JL
    Russell, NH
    BONE MARROW TRANSPLANTATION, 1999, 23 : S217 - S217
  • [34] Single blinded, randomized study of low-dose cyclophosphamide followed by G-CSF or sequential GM-CSF/G-CSF for mobilization of CD34+cells to support autologous transplantation - Interim analysis.
    Sarkodee-Adoo, CB
    Hakimian, RR
    Meisenberg, B
    Rapoport, AS
    Badros, A
    Guo, CF
    Phillips, GL
    BLOOD, 2002, 100 (11) : 829A - 829A
  • [35] A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+Cells Mobilization and Autografting in Hematological Malignancies
    Brunello, Lucia
    Giaccone, Luisa
    Fornaro, Maria Jose
    Scaldaferri, Matilde
    Redoglia, Valter
    Omede, Paola
    Festuccia, Moreno
    Ciccone, Giovannino
    Massaia, Massimo
    Ferrero, Dario
    Cavallo, Federica
    Palumbo, Antonio
    Cattel, Francesco
    Evangelista, Andrea
    Boccadoro, Mario
    Bruno, Benedetto
    BLOOD, 2016, 128 (22)
  • [36] Safe G-CSF Mobilization of Thalassemia Patient CD34+Cells and Effective Globin Gene Transduction for Therapeutic Infusion
    Boulad, Farid
    Wang, Xiuyan
    Taylor, Clare
    Qu, Jinrong
    Ferro, Leda
    Karponi, Garie
    Bartido, Shirley
    Giardina, Patricia
    Heller, Glenn
    Prockop, Susan E.
    Maggio, Aurelio
    Sadelain, Michel
    Riviere, Isabelle
    MOLECULAR THERAPY, 2013, 21 : S25 - S25
  • [37] The kinetics of G-CSF mobilization of CD34+ cells in healthy people
    Stroncek, DF
    Clay, ME
    Herr, G
    Smith, J
    Jaszcz, WB
    Ilstrup, S
    McCullough, J
    TRANSFUSION MEDICINE, 1997, 7 (01) : 19 - 24
  • [38] Kinetics of CD34+cells during mobilisation using CTX plus G-CSF allows for an early identification of "not mobilizing" patients and can be used as criteria for early "on demand" use of plerixafor
    Milone, G.
    Tripepi, G.
    Ancora, F.
    Spadaro, A.
    Bartolozzi, B.
    Di Mercurio, S.
    Martino, M.
    Nozzoli, C.
    La Fauci, A.
    Amico, I.
    Iacopino, P.
    Saccardi, R.
    Guidi, S.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S246 - S246
  • [39] Sufficient mobilisation of peripheral blood stem cells by single dose of pegylated G-CSF compared with daily G-CSF in patients with lymphoproliferative malignancies
    Putkonen, M
    Itälä, M
    Kauppila, M
    Rauhala, A
    Remes, K
    BONE MARROW TRANSPLANTATION, 2006, 37 : S160 - S160
  • [40] CD34+CD38- primitive progenitor cells constitute a lower proportion of CD34+ cells in patients receiving chemotherapy with G-CSF mobilization than patients and normal donors receiving G-CSF alone.
    Lagarias, DM
    Richman, CM
    BLOOD, 1998, 92 (10) : 723A - 723A